Literature DB >> 10867261

Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer's patch segment.

A M Torché1, H Jouan, P Le Corre, E Albina, R Primault, A Jestin, R Le Verge.   

Abstract

We investigated the ability of pig ileal Peyer's patch segments to transport intestinal poly (D,L-lactide-co-glycolide) microspheres (PLGA MS) from intestinal lumen across the mucosae using in situ and ex vivo segments with confocal laser scanning microscopy (CLSM) and transmission electronic microscopy (TEM). From a global aspect, CLSM suggested that PLGA MS were translocated by M cells labelled with a FITC-conjugated anti-cytokeratin peptide 18, and transported through the follicle-associated epithelium (FAE) in the dome area in both types of experiments. At the ultrastructural level, TEM showed the traffic of PLGA MS throughout M cells, their transport into the basolateral invaginations of the M cells and their subsequent migration into the dome area and the follicular area in contact with macrophages and lymphatic vessels. Although in situ experiments allowed following the migration of PLGA MS until mesenteric lymph nodes, an ex vivo model could be used as a useful tool to study the targeting ability of PLGA MS formulations to the gut-associated lymphoid tissue (GALT).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867261     DOI: 10.1016/s0378-5173(00)00364-1

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: contribution of reduced clearance.

Authors:  Rajendra S Kadam; David W A Bourne; Uday B Kompella
Journal:  Drug Metab Dispos       Date:  2012-04-12       Impact factor: 3.922

Review 2.  Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery.

Authors:  Christopher L Grigsby; Kam W Leong
Journal:  J R Soc Interface       Date:  2009-09-04       Impact factor: 4.118

Review 3.  3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers.

Authors:  Thomas Tyrel Goodman; Chee Ping Ng; Suzie Hwang Pun
Journal:  Bioconjug Chem       Date:  2008-09-13       Impact factor: 4.774

4.  Fabrication of poly(D, L-lactic acid) nanoparticles as delivery system for sustained release of L-theanine.

Authors:  Chandrika Ravi; Khan Zaved Ahmed; Mandal Abul Kalam Azad
Journal:  IET Nanobiotechnol       Date:  2019-09       Impact factor: 1.847

5.  Increased number of intestinal villous M cells in levamisole -pretreated weaned pigs experimentally infected with F4ac⁺ enterotoxigenic Escherichia coli strain.

Authors:  H Valpotić; A Kovšca Janjatović; G Lacković; F Božić; V Dobranić; D Svoboda; I Valpotić; M Popović
Journal:  Eur J Histochem       Date:  2010       Impact factor: 3.188

Review 6.  Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines.

Authors:  Anil Mahapatro; Dinesh K Singh
Journal:  J Nanobiotechnology       Date:  2011-11-28       Impact factor: 10.435

7.  Antiretroviral Drugs-Loaded Nanoparticles Fabricated by Dispersion Polymerization with Potential for HIV/AIDS Treatment.

Authors:  Oluwaseun Ogunwuyi; Namita Kumari; Kahli A Smith; Oleg Bolshakov; Simeon Adesina; Ayele Gugssa; Winston A Anderson; Sergei Nekhai; Emmanuel O Akala
Journal:  Infect Dis (Auckl)       Date:  2016-03-20

8.  A blue fluorescent labeling technique utilizing micro- and nanoparticles for tracking in LIVE/DEAD® stained pathogenic biofilms of Staphylococcus aureus and Burkholderia cepacia.

Authors:  Mareike Klinger-Strobel; Julia Ernst; Christian Lautenschläger; Mathias W Pletz; Dagmar Fischer; Oliwia Makarewicz
Journal:  Int J Nanomedicine       Date:  2016-02-05

Review 9.  Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds.

Authors:  Xin Nie; Zhejie Chen; Lan Pang; Lin Wang; Huajuan Jiang; Yi Chen; Zhen Zhang; Chaomei Fu; Bo Ren; Jinming Zhang
Journal:  Int J Nanomedicine       Date:  2020-12-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.